| Customization: | Available |
|---|---|
| CAS No.: | 128-13-2 |
| Formula: | C24h39o4 |
|
Still deciding? Get samples of US$ 10/G
Order Sample
|
| Shipping Cost: | Contact the supplier about freight and estimated delivery time. |
|---|
| Payment Methods: |
|
|---|---|
| Support payments in USD |
| Secure payments: | Every payment you make on Made-in-China.com is protected by the platform. |
|---|
| Refund policy: | Claim a refund if your order doesn't ship, is missing, or arrives with product issues. |
|---|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Identification |
| Name | Ursodeoxycholic acid, UDCA, CAS 128-13-2 |
| Structure | |
| Other name | URSODEOXYCHOLIC ACID ursodiol 128-13-2 ursodeoxycholate UDCA UrSO |
| Key words | API,dissolves or prevents cholesterol gallstones by blocking hepatic cholesterol production; treatment of liver disease for centuries. Ursodeoxycholic acid, CAS 128-13-2; Ursodeoxycholic acid, CAS 128-13-2 supplier; Ursodeoxycholic acid, CAS 128-13-2 distributor; CAS 128-13-2; Ursodeoxycholic acid, CAS 128-13-2 manufacturer; Ursodeoxycholic acid, CAS 128-13-2 wholesale; China Ursodeoxycholic acid, CAS 128-13-2 manufacturers; Ursodeoxycholic acid, CAS 128-13-2 cost; Ursodeoxycholic acid, CAS 128-13-2 buy; Ursodeoxycholic acid, CAS 128-13-2 for sale |
| CAS NO. | 128-13-2 |
| Molecular Formula | C24H40O4 |
| Molecular Weight | 392.58 g/mol |
| Chemical and Physical Properties | |
| Appearance | White or almost white crystalline powder |
| Melting point | 203-204 °C(lit.) |
| Quality standard | EP |
| Application | |
| Drug Indication | An incomplete list of the current uses is as follows: -Reduction in gallstone formation, either in patients with gallstones unfit for cholecystectomy, or obese patients undergoing rapid weight loss to prevent gallstone formation. -For the treatment of primary biliary cholangitis -To aim to improve bile flow in patients with cystic fibrosis -In newborn infants with impaired bile flow -After bariatric surgery, to prevent cholelithiasis due to the rapid weight loss with biliary cholesterol oversaturation and also biliary diskinesia secondary to abnormalities in cholecystokinin and biliary enervation |
| Formulations/Preparations | tablet, capsule |
| Handling and storage | |
| Safety and Hazards | Causes skin irritation Causes serious eye irritation |
| Handling and storage | Hazardous material is properly classed, described, packaged, marked, labeled, and in condition for shipment as required. |
| Sample package | Aluminium foil bag |
| Commercial package | fiber drum,with UN1230 |
| UN Code | UN1230 |
| HS Code | 2942000000 |
| Shipping group | UN1230 - class 3 - PG 2 - Methanol, solution |
| Sales restriction | As UN1230 hazard drug |
| Origin | China |
| Technical Support | |
| Ursodeoxycholic acid STD Data sheet | Yes |
| Ursodeoxycholic acid MSDS | Yes |
| Ursodeoxycholic acid COA | Yes |
| Ursodeoxycholic acid Dangerous Package Certificate | Yes |
| Supply ability | |
| Monthly capacity | 1ton |
| GMP | None |
| Related APIs | |
| Related APIS | Chenodeoxycholic Acid (CDCA) Hyodeoxycholic acid |
){kind=link}